GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (OSTO:ALZ) » Definitions » Common Stock

Alzinova AB (OSTO:ALZ) Common Stock : kr11.71 Mil (As of Sep. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Alzinova AB Common Stock?

Alzinova AB's quarterly common stock increased from Mar. 2023 (kr8.53 Mil) to Jun. 2023 (kr11.71 Mil) but then stayed the same from Jun. 2023 (kr11.71 Mil) to Sep. 2023 (kr11.71 Mil).

Alzinova AB's annual common stock stayed the same from Dec. 2020 (kr4.15 Mil) to Dec. 2021 (kr4.15 Mil) but then increased from Dec. 2021 (kr4.15 Mil) to Dec. 2022 (kr8.53 Mil).


Alzinova AB Common Stock Historical Data

The historical data trend for Alzinova AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alzinova AB Common Stock Chart

Alzinova AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Common Stock
Get a 7-Day Free Trial 1.44 2.01 4.15 4.15 8.53

Alzinova AB Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.53 8.53 8.53 11.71 11.71

Alzinova AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Alzinova AB (OSTO:ALZ) Business Description

Traded in Other Exchanges
Address
Pepparedsleden 1, Molndal, SWE, SE-431 83
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is also engaged in development of a specific oligomer-directed vaccine (ALZ-101), as well as on the development of diagnostics based on a monoclonal antibody. The product is in clinical development as a therapeutic vaccine for the treatment of Alzheimer's.

Alzinova AB (OSTO:ALZ) Headlines

No Headlines